‘Socialized Research’ and ‘Privatized Profits’: California's Gene Therapy Research and Million Dollar Plus Treatments
By David Jensen,
The California Stem Cell Report
| 08. 09. 2021
“One and Done” — If Companies Actually Go to Market
Only eight days after the California stem cell agency approved its most recent award for its $60 million battle against sickle cell disease came a cautionary note from 3,000 miles away.
The note sounded financial misgivings regarding the proposed, gene-editing treatments that have been highly touted as a possible cure for sickle cell disease, an affliction that occurs predominantly among African-Americans and other minorities.
The concerns came from the 60-member Congressional Black Caucus. Million-dollar plus price tags were the main matter for the federal lawmakers. “We are troubled that access to these medicines is anything but guaranteed for the patients who would benefit most from them,” the lawmakers said in a letter to the head of the mammoth U.S. Department of Health and Human Services.
The timing of the July 28 letter appears merely coincidental to the approval on July 20 of an $8.4 million gene-therapy grant by the California Institute for Regenerative Medicine (CIRM), as the stem cell agency is officially known.
The caucus letter was not directed at CIRM, which is likely not even on the lawmakers’...
Related Articles
By Jared Whitlock, Endpoints News | 10.09.2025
When Nirnay Murthy learned about a treatment for his toddler son’s rare condition, relief quickly gave way to disappointment.
A one-time gene therapy called Zolgensma from the Swiss drugmaker Novartis can halt spinal muscular atrophy, a deadly condition that causes...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Daniel Hildebrand, The Humanist | 10.01.2025
When most people hear the word eugenics, they think of dusty history textbooks and black-and-white photographs: forced sterilizations in the early 20th century, pseudoscientific charts measuring skulls, the language of “fitness” used to justify violence and exclusion. It feels like...